CJC-1295 (No DAC)
GHRH analog (Mod-GRF 1-29)
$60.00
Size
Secure payment by card link, Zelle or crypto · discreet packaging · fast USPS shipping
Modified GRF (1-29) GHRH analog without the Drug Affinity Complex, studied for short-acting GH-pulse potentiation. ≥98% HPLC purity.
Research applications
- 01GHRH receptor research
- 02GH-pulse potentiation studies
- 03Somatotropic axis models
- Sizes
- 5 mg · 10 mg
- Purity
- ≥98%
- Molecular formula
- C165H269N47O46
- Sequence / identity
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg
- Supplied form
- Lyophilized powder
- Storage
- Refrigerate at 2–8 °C; −20 °C for long-term. Protect from heat, moisture & light.
- Container
- Sealed clear glass research vial
- ✓Compound identity & sequence
- ✓Measured purity (HPLC %)
- ✓Sequence / identity confirmation
- ✓Batch / lot number
- ✓Analytical test date
- ✓Supplied form & storage
Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.
Batch documentation
Batch-specific analytical documentation supports receiving, verification, and internal recordkeeping.
Storage guidance
Refrigerate the supplied material, freeze for long-term storage, and protect it from heat, moisture, and light.
Research-only labeling
Every vial is clearly identified for laboratory research use only — not for human or veterinary use.
What is CJC-1295 without DAC?
CJC-1295 without DAC, also catalogued as Modified GRF (1-29) or Mod GRF, is a 29-amino-acid synthetic analog of growth-hormone-releasing hormone (GHRH). It is based on the first 29 residues of GHRH, the shortest segment that retains receptor activity, with a small number of amino-acid substitutions introduced to slow enzymatic cleavage. "No DAC" means the peptide lacks the Drug Affinity Complex, the lysine-linked group that lets the DAC version bind albumin.
That difference matters at the bench: without the albumin-binding group, the peptide behaves as a short-acting GHRH analog, which is what many pulse-type experimental designs require. It is available from V8 Peptides as lyophilized powder in 5 mg and 10 mg vials.
Where it is used in the lab
- GHRH-receptor binding and cAMP signaling assays in pituitary cell models
- Pulse-type GH-release studies that need a short-acting GHRH analog
- Paired experiments with ghrelin-receptor agonists such as ipamorelin
For laboratory research use only; not for human consumption.
CJC-1295 (No DAC) specifications
| Compound | CJC-1295 without DAC (Mod GRF 1-29) |
|---|---|
| Class | 29-amino-acid GHRH analog |
| Vial sizes | 5 mg · 10 mg |
| Identity | Sequence confirmed on the batch COA |
| Purity | ≥98% (HPLC) |
| Supplied form | Lyophilized powder, sealed glass vial |
| Storage | 2–8 °C; −20 °C long-term; protect from heat, moisture and light |
| Documentation | Batch-specific COA |
Reconstitution & storage for research
With two vial sizes, it helps to pick the target concentration first and work backwards. Adding 2 mL of diluent to the 5 mg vial gives 2.5 mg/mL, while the same 2 mL in the 10 mg vial gives 5 mg/mL. To hold both sizes at 2.5 mg/mL, add 4 mL to the 10 mg vial. At 2.5 mg/mL, a 100 µL aliquot contains 250 µg. For other volumes, the reconstitution calculator returns mg/mL and per-aliquot content instantly.
A sterile diluent such as bacteriostatic water is the usual choice for multi-use research vials. Let the diluent trickle down the vial wall, give the powder time to wet, and roll the vial between your fingers until no particles remain. Avoid shaking or vortexing at high speed.
Storage conditions
- Dry material: refrigerated (2–8 °C) on arrival; frozen (−20 °C) when it will not be used soon.
- Handling: limit exposure to warmth, moisture and light, and wipe the stopper with an alcohol swab before each puncture.
- Reconstituted material: store at 2–8 °C, note the date and mg/mL value in your lab record, and freeze single-use aliquots rather than refreezing one vial.
Quality & testing
Purity for CJC-1295 (No DAC) is measured by HPLC on a per-batch basis, with a ≥98% release threshold. The matching Certificate of Analysis is posted at /coa, which lets a lab verify what it received instead of relying on a generic specification sheet.
- Chromatographic purity (HPLC %)
- Identity check for the stated compound
- Lot number and test date for traceability
- Form supplied and recommended storage
Each sealed vial carries research-use labeling and ships domestically in the US. Orders are paid by invoice or Zelle.
Related lab guides
- CJC-1295 (No DAC) research overview
- CJC-1295 (No DAC) reconstitution and storage
- How CJC-1295 (No DAC) purity is tested
- CJC-1295 (No DAC) structure and synthesis
- CJC-1295 vs. ipamorelin
- Reconstitution calculator guide
Other GH-axis research peptides in the catalog: CJC-1295 (No DAC) + Ipamorelin blend, Ipamorelin 10 mg, Sermorelin.
Frequently Asked Questions
What purity is CJC-1295 (No DAC)?+
CJC-1295 (No DAC) is verified to ≥98% purity by HPLC, with identity confirmed by batch-specific analytical documentation (COA) published on our site.
How is CJC-1295 (No DAC) supplied and stored?+
CJC-1295 (No DAC) is supplied as a lyophilized powder. Refrigerate at 2–8 °C, or freeze at −20 °C for long-term storage. Protect from heat, moisture, and light.
Do you provide a Certificate of Analysis?+
Yes — every batch ships with batch-specific analytical documentation (COA) to support qualified receiving and internal recordkeeping.
Is CJC-1295 (No DAC) approved for human use?+
No. This product is sold strictly for laboratory research and development purposes and is not for human or animal consumption.
